PlexusDx now compounds pharmaceutical-grade tirzepatide for patients across all 50 states, making this innovation accessible without insurance barriers
Estimated read time: 4-5 minutes This archived news story is available only for your personal, non-commercial use
Others need their full maintenance dose indefinitely
Published clinical research has characterised the compound in controlled trials: a Phase 2 obesity trial reported dose-dependent body-weight change in the study population (Jastreboff et al., 2023), and a separate Phase 2 trial investigated the GIP/GLP-1/glucagon agonist in people with type 2 diabetes (Rosenstock et al., 2023)
For most women hot flushes begin during the perimenopause unfortunately the earlier the perimenopause the longer the hot flushes last
For example, one placebo-controlled study on runners who had completed a half marathon found no statistically significant improvements in muscle pain after the bout